Membranes from rabbit aorta and from rabbit and rat kidney cortex possess high-affinity (Kd = 10-10 M) specific binding sites for atrial natriuretic factor (ANF). Similar high-affinity sites are present in an established cell line from pig kidney, LLC-PK,. Results of fractionation studies indicate that the receptors are localized in the plasma membrane of these tissues. The binding is time-dependent and saturable. An excellent quantitative correlation was found between the affinity of synthetic ANF and analogs of intermediate activity to aorta membranes and the half-maximal concentration needed for relaxation of rabbit aorta rings contracted by addition of serotonin. Furthermore, the binding affinity of the receptor in kidney membranes is consistent with the concentration required for in vivo natriuresis in the rat. Biologically inactive synthetic ANF fragments and other peptide hormones such as angiotensin II and vasopressin do not significantly inhibit binding. These data suggest that the receptors for ANF in vascular and renal tissues are responsible for mediating the physiological actions of this peptide in these target tissues.
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A possible role for the cardiac atria in the regulation of extracellular fluid volume and electrolyte concentration has been shown by the induction of sodium and water excretion in response to changes in intraatrial pressure and stretch of the atrial wall (1) . The cardiac atria possess granules that have the appearance of secretory granules (2-4) and whose number can be altered by manipulation of the water-electrolyte balance in experimental animals (5) . Crude extracts of atria from several species have been shown to possess potent diuretic and natriuretic activity when given intravenously to rats (6) . Subcellular fractionation (7) and immunocytochemistry (8) indicated that these granules are storage sites for an atrial natriuretic factor (ANF). Furthermore, in vitro, atrial extracts were shown to be potent vasorelaxants (9) (10) (11) (12) (13) (14) . As little as 0.0006 atrial equivalent per milliliter gave 50% relaxation of precontracted aorta tissues (12) . In vivo, ANF caused lowering of mean arterial blood pressure in normal and hypertensive animals (6, 15, 16) .
Recently, a family of peptides has been isolated from acidic extracts of rat (10, 11, (19) (20) (21) (22) and human (23) atria and sequenced independently by several laboratories. From rat atria, the longest peptide that has been reported contains 33 amino acids, 1, and was isolated as the free COOH-terminal tyrosine acid (20, 21) . Shorter rat ANF peptides are truncated at either the NH2 or COOH terminus. 5 10 H-Leu -Ala-Gly-Pro -Arg-Ser -Leu-Arg-Arg-Ser-Ser- 15 20 Cys-Phe-Gly-Gly-Arg-Ile -Asp-Arg-Ile -Gly-Ala--30
Gln -Ser-Gly-Leu-Gly-Cys -Asn-Ser-Phe-Arg-Tyr-OH 1 A peptide consisting of residues 8-33, designated sANF, has been synthesized (21, 24) and shown to possess full biological activity (12, 16, 21, 24) . The IC50 of sANF for relaxation of precontracted rabbit aorta rings is 550 pM (12) . The amount of sANF required for half-maximal natriuresis when given intravenously by infusion to conscious rats is 60-100 pmol/kg min and 3.6 pmol/kg min when given directly into the renal artery of dogs (16) . The biological activity and isolation of ANF were recently reviewed (25) .
Although a physiological role for endogenous ANF is implied by the potent biological activity of these peptides, the existence of a circulating form of ANF or specific receptors for ANF in target tissues has not been demonstrated. In this report we describe specific receptors for ANF as defined by binding of radioiodinated sANF of high specific activity to membranes from vascular and renal tissues. The nonradioactive monoiodotyrosine derivative of sANF (I-sANF) is shown to possess both vasorelaxant and natriuretic activity. A high-affinity receptor is present in aorta and kidney cortex and in an established kidney cell line, LLC-PK1 (26) . The specificity of the 1251-sANF binding is demonstrated by markedly reduced binding in the presence of unlabeled sANF and analogs with similar biological profiles.
MATERIALS AND METHODS
Materials. The synthetic ANF peptides (1 and Table 2) were synthesized as described (21, 24 
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tion was achieved by a linear gradient of acetonitrile (0-50%) over 40 min at a flow rate of 1 ml/min. One-minute fractions were collected for the first 20 min, after which 0.5-min fractions were collected; 10-1.l aliquots were removed and radioactivity was counted in a Packard y-spectrometer. BSA was added to the radiolabeled peptide fractions (to ca. 1 mg/ml) in the aqueous acetonitrile buffer and the fractions were stored at 40C. Nonradioactive I-sANF was prepared for determination of biological activity. The reaction conditions were similar to those used for the preparation of radiolabeled sANF but on a larger scale. A greater molar ratio of iodide to peptide was used to increase the yield of I-sANF. The HPLC fractions containing sANF and I-sANF were lyophilized, and the peptide content was quantitated by SPINCO amino acid analySiS.
Membrane preparation. Aortae and kidneys were taken from New Zealand White rabbits (3-12 months old) or purchased from Pel-Freez and from Charles River SpragueDawley male rats (3-4 months old). The aortae were frozen, pulverized, and then homogenized with a Brinkmann Polytron in cold homogenization buffer containing 1 mM NaHCO3 and 0.1% bacitracin (pH 7.5). Kidneys were removed rapidly and placed in cold physiological saline buffer. The cortex was dissected from the kidney and minced in homogenization buffer. Membranes were prepared from fresh tissue or tissue frozen at -80'C as described (28) .
Porcine kidney LLC-PK1 cells were grown in medium M199 (GIBCO) supplemented with 5% fetal bovine serum and glutamine. The confluent cells, with the marked presence of dome formation typical of transporting epithelial cells, were used for membrane preparation. The incubation medium was removed and the cells were rinsed twice with physiological saline before being scraped from the flasks into homogenization buffer. The cells were disrupted with a Dounce homogenizer and membranes were prepared as described above.
The crude kidney membranes were further purified on discontinuous sucrose gradients (28) . The membranes were resuspended in 53% sucrose (wt/wt) and overlaid successively with layers of 41%, 37%, 33%, and 8.5% sucrose. The samples were centrifuged overnight at 26,000 rpm in a Beckman SW28 rotor. Membranes found at the interface between the layers were removed, diluted with buffer, centrifuged, and resuspended in 1 mM bicarbonate buffer with 0.1% bacitracin. Protein concentrations were determined by the method of Lowry et al. (29) with BSA as standard.
Binding of1251-sANF to membranes. Binding studies were performed at 0C in a buffer containing 50 mM Hepes (pH 7.5), 5 mM MgCl2, 1.0 or 0.2% BSA, and 0.1% bacitracin, in a total volume of 0.5 ml. '251-sANF (20, 000-100,000 cpm) and the competing ligand, when used, were combined in the assay tube followed by addition of membranes to initiate the binding reaction. Binding was allowed to proceed for 1 hr at 0°C to equilibrium. Bound 1251-sANF was separated from free ligand by rapid dilution of the membrane mixture with 2.5 ml of ice-cold 0.15 M NaCl and immediate filtration through polyethyleneimine-treated (30) Whatman GF/C filters under vacuum. The reaction tube and filters were washed two times with an additional 5 ml of cold buffer. Filters were assayed for radioactivity in a Packard y-spectrometer with ca. 67% efficiency. Analysis of the binding data was performed by using the LIGAND computer program of Munson and Rodbard (31) or by a nonlinear four-parameter least squares analysis. In order to ascertain whether the 1251_ sANF was stable to the incubation conditions, bound and free ligand was assayed by HPLC. Aliquots of the supernatant were assayed directly, while the membrane-bound ligand was extracted with 80% acetonitrile in 1 M acetic acid and lyophilized before analysis.
Vasorelaxant activity in rabbit aorta rings. The vasorelaxant activity of sANF and synthetic fragments was determined as described (12) . Thoracic aorta ring segments from New Zealand White rabbits (2.0-2.6 kg) were contracted by addition of serotonin (300 nM) with the vasodilator peptides added cumulatively once the contraction reached an equilibrated plateau. IC50 values were obtained by linear regression analysis using logarithmic transformation of the concentrations.
RESULTS
lodination and Characterization of 2.51-sANF. lodination and HPLC purification of sANF with the present procedure results in a monoiodinated peptide with maximal theoretical specific radioactivity of 600 0Ci/,4g, corresponding to one iodine per peptide molecule. The radioiodinated sANF was eluted from the reversed-phase HPLC column well separated (ca. 2 min) from the unlabeled and diiodo forms of sANF (Fig. 1) . By using a low ratio of iodide to peptide during the radioiodination procedure, only a single iodinated product Nonradioactive I-sANF was produced by a procedure similar to that described above (Fig. 1 ) in quantities sufficient for determination of biological activity. Under optimal conditions, conversion of sANF to I-sANF was -48% based ) on the absorbance of the respective HPLC fractions and by amino acid analysis. lodinated sANF gave complete relaxation of serotonin-contracted rabbit (IC50 = 1650 pM) and rat (IC50 = 1050 pM) aortae but required a slightly higher concentration than sANF (550 pM and 850 pM, respectively) for 50% relaxation. In anesthetized rats, I-sANF and sANF produced equal natriuretic activity (5315 and 5998 tiEq/min-gg, respectively). Previous studies have shown that the COOHterminal tyrosine is not necessary for biological activity (10).
Binding of 2.51-sANF. 1251-sANF was found to bind specifically to crude rabbit aorta membranes. Scatchard analysis of the data obtained in one experiment by competition with unlabeled sANF revealed a single high-affinity receptor species (Kd = 1.29 x 10-1O M, 96 fmol/mg of protein, Fig. 2) . Four replicate determinations resulted in a mean Kd of 9.2 + 2.3 x 10-11 M (mean ± SD) (see Table 2 ). Binding was linear over the range of 6-100 ,ug of membrane protein. By HPLC analysis, the bound ligand was identical to the original 125I_ sANF sample.
The binding profile for _251-sANF in crude membranes prepared from kidney cortex of rabbits was more complex than that observed for the rabbit aorta. The data were best described by a two-site model-e.g., a high-and a low-affinity site (Fig. 3) . The low-affinity binding sites appeared in varying amounts in different preparations. The high-affinity sites have similar properties to the high-affinity sites in aorta membranes (Kd = 5.2 x 10-11 M, 35 fmol/mg). Similar results were found for membranes prepared from either fresh or frozen tissues and for membranes stored at -80°C. Discontinuous sucrose gradient fractionation of these membranes (Table 1 ) resulted in the 3-fold enrichment of the highaffinity sites and loss of the low-affinity sites in the lowdensity sucrose fraction that contains principally plasma membranes.
The specificity of sANF binding to the high-affinity rabbit aorta and renal receptors is shown by the absence of competition by several biologically inactive sANF intermediates (Table 2 ) and the unrelated peptide hormones, including angiotensin II, insulin, somatostatin-28, substance P, thyrotropin-releasing hormone, and vasopressin, at concentrations of 1 ,M. Furthermore, the IC50 values for vasorelaxation of sANF analogs parallel the Kd values of these sANF analogs for binding to rabbit aorta membranes with reduced binding affinity observed for compounds having reduced vasorelaxant activity (Table 2 IC50 values (correlation coefficient = 0.86) for sANF in rabbit aorta provides evidence that this tissue is a primary target for the biological action of ANF. In contrast to the results obtained in rabbit kidney membranes, only low-affinity binding was observed in crude membranes prepared by an identical procedure from rat kidney cortex. The crude rat kidney preparation was not stable to freezing and had markedly reduced binding activity when stored at 4°C for 24-48 hr. HPLC analysis of the free and membrane-bound ligand revealed extensive degradation of the ligand during the 30-min incubation at 0°C. Partial purification of the crude membranes by discontinuous sucrose gradient centrifugation removed most of the degrading activity and revealed high-affinity sites (Kd = 4.9 x 10-1 M) in the low-density plasma membrane fraction.
Membranes have also been prepared from the homogeneous population of LLC-PK1 kidney cells by procedures described above. Preliminary experiments have revealed a single class of high-affinity sites (Kd = 1.98 x 10-10 M) and a similar density of sites (65 fmol/mg of protein) as observed in the rabbit and rat renal membranes.
DISCUSSION
Conditions have been optimized for the preparation of an iodinated analog of sANF with retention of both vasorelaxant and natriuretic activity. Radiolabeled monoiodinated sANF was prepared by a similar procedure and, when separated from unlabeled sANF and 125I2-sANF by reversedphase HPLC, has maximal specific radioactivity and good long-term stability. High specific binding of 125I-sANF was tSerotonin contracted, 300 nM; 95% confidence limits are 18-47% for four or more replicates.
tCrude membrane fraction. §Partially purified plasma membrane fraction.
detected in membranes prepared from vascular and renal tissues and from an established kidney cell line. Low nonspecific binding (<2% of the total radioactivity added) was observed to the polyethyleneimine-treated glass fiber filters or to the membrane preparations in the presence of 1 ,uM sANF.
High-affinity sANF receptor sites are present in membranes derived from rabbit aorta. The specificity of binding of 1251-sANF is shown by inhibition of binding with biologically active sANF intermediates and not by inactive intermediates or by nonrelated peptide hormones. The observed dissociation constant is consistent with the concentration of sANF or its analogs needed for relaxation of rabbit aortic rings.
Similar high-affinity receptors were found in renal tissues. In some preparations of rabbit kidney membranes, high-and low-affinity sites were detected. However, partial purification of the membranes by sucrose gradient centrifugation resulted in an enrichment of the high-affinity binding sites in the plasma membrane fraction with removal of the apparent low-affinity binding. The rat kidney cortex membranes also possess the high-affinity sites that were only observed after partial purification of the crude membranes. HPLC analysis of the 1251-sANF from the binding mixture indicated varying degrees of degradation of the ligand in the crude rat and rabbit preparations. This observation probably accounts for the apparent low-affinity sites.
The LLC-PK, cells are a homogeneous population established from porcine kidney that retain characteristics of polar transporting epithelial cells. The high-affinity sites observed in the rat and rabbit kidney membranes could be of vascular origin since the kidney cortex contains many cell types, including vascular smooth muscle. However, the presence of similar high-affinity sites on the LLC-PK1 cells indicates that the kidney receptor is probably of renal tubular origin.
The site of action of ANF in the kidney has not yet been defined. Micropuncture studies indicate that ANF exerts its effects in the distal tubules (32, 33) . ANF does not alter the active sodium ion transport by inhibition of the Na+,K+-ATPase (34) (35) (36) or sodium ion flux in the proximal tubule as measured by Na NMR and tubular oxygen consumption (M. J. Avison, S. Gullans, and R. Shulman, personal communication) or oxygen consumption in kidney slices (34) . The LLC-PK1 cells exhibit properties that are consistent with both distal (37) (38) (39) , including the medullary portion of the thick ascending limb of the loop of Henle (39) , and proximal tubules (26, 40, 41) . The demonstration of specific highaffinity ANF receptors in these cells makes this cell line a possible model system for studying the direct effect of ANF on renal cells.
The relevance of ANF receptors to the biological action of ANF is implied by the correlation of the binding constants with the IC50 values for biological activity. The Kd value of the high-affinity renal sites is consistent with an estimated plasma concentration of sANF that produces natriuresis after a bolus injection of sANF into an experimental rat [e.g., 3 nM, based on a plasma volume of 30 ml/kg and instantaneous distribution (17) ]. Therefore, these data support a physiological role for endogenous ANF in both the vasculature and the kidneys. Since specific receptors for ANF in known target tissues have now been demonstrated, experiments can be undertaken to study the role of these receptors in the mechanism of action of ANF. It will be possible now to determine whether receptor affinity, number, or availability can be correlated with the variable sensitivities to ANF that have been observed in vascular tissues and in normal and hypertensive animals (14) (15) (16) 18 ).
Note Added in Proof. The presence of high-affinity specific receptors for ANF which mediate the inhibitory action of ANF in steroidogenesis has also been observed in bovine adrenal glomerulosa cells [observed by De Lean et al. (42, 43) ].
